Healthcare provider profile · identity verified

David J Rawcliffe, DO

Family Practice · BANGOR, ME · NPI 1225155906

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	470	120
Lisinopril	Lisinopril	344	87
Amlodipine Besylate	Amlodipine Besylate	219	59
Levothyroxine Sodium	Levothyroxine Sodium	196	55
Metoprolol Succinate	Metoprolol Succinate	186	51
Eliquis	Apixaban	169	39
Pantoprazole Sodium	Pantoprazole Sodium	168	50
Metformin Hcl	Metformin Hcl	155	38
Tamsulosin Hcl	Tamsulosin Hcl	147	42
Losartan Potassium	Losartan Potassium	141	39
Metoprolol Tartrate	Metoprolol Tartrate	125	34
Omeprazole	Omeprazole	125	34
Furosemide	Furosemide	123	43
Mounjaro	Tirzepatide	116	13
Gabapentin	Gabapentin	107	37
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	100	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	99	31
Carvedilol	Carvedilol	91	23
Ozempic	Semaglutide	90	19
Sertraline Hcl	Sertraline Hcl	86	24
Albuterol Sulfate Hfa	Albuterol Sulfate	82	34
Famotidine	Famotidine	80	28
Hydrochlorothiazide	Hydrochlorothiazide	77	25
Prednisone	Prednisone	75	36
Trazodone Hcl	Trazodone Hcl	73	23
Pregabalin	Pregabalin	72	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	19
Trulicity	Dulaglutide	56	12
Allopurinol	Allopurinol	55	17
Escitalopram Oxalate	Escitalopram Oxalate	51	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	50	14
Finasteride	Finasteride	49	12
Metformin Hcl Er	Metformin Hcl	48	13
Clopidogrel	Clopidogrel Bisulfate	47	14
Jardiance	Empagliflozin	46	12
Suboxone	Buprenorphine Hcl/Naloxone Hcl	46	suppressed
Potassium Chloride	Potassium Chloride	45	12
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Ondansetron Odt	Ondansetron	41	13
Tramadol Hcl	Tramadol Hcl	41	17
Pravastatin Sodium	Pravastatin Sodium	39	suppressed
Montelukast Sodium	Montelukast Sodium	38	12
Ezetimibe	Ezetimibe	37	suppressed
Tresiba Flextouch U-100	Insulin Degludec	36	12
Nitroglycerin	Nitroglycerin	34	22
Triamcinolone Acetonide	Triamcinolone Acetonide	33	21
Fluconazole	Fluconazole	32	11
Fluticasone Propionate	Fluticasone Propionate	32	13
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Simvastatin	Simvastatin	30	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	29	17
Diazepam	Diazepam	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Azithromycin	Azithromycin	27	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Levetiracetam	Levetiracetam	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Nystatin	Nystatin	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Atenolol	Atenolol	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Flecainide Acetate	Flecainide Acetate	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	11
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	13	13
Buprenorphine Hcl	Buprenorphine Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Enalapril Maleate	Enalapril Maleate	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Lactulose	Lactulose	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Risperidone	Risperidone	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Budesonide Dr	Budesonide	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error